|    editor@medjpps.com

www.medjpps.com

Received date : 30-04-2022 Revised date : 27-06-2022 Accepted date : 25-07-2022 Published date : 30-09-2022

Mediterr J Pharm Pharm Sci 2 (3): 17 - 23, 2022

DOI: https://doi.org/10.5281/zenodo.7115139

Original Research


Assessment of knowledge and awareness of community pharmacists toward epilepsy

Muhammed Mansour, Aisha E. Alkadi , Heba A. Alnayif and Souad Qtannish



Abstract :

Community pharmacist plays an essential role in educating epileptic patients about their disease and medications. Improving the patient’s awareness may lead to improved compliance and decreased drug-drug interaction and ultimately improved their quality of life. Pharmacists can detect the emergence of health problems and can help prevent the progression of comorbidities. Considering the complexity of treating epilepsy and the lack of information about pharmacists’ contributions to epilepsy management, pharmacists performed pharmaceutical counselling, pharmaco-therapeutic follow-up and systematic measurement and evaluation of findings and increased medication adherence of patients with epilepsy. This study aimed to assess the community pharmacist's knowledge of epilepsy and their treatment by antiepileptic drugs in Libya. The design of the study is a cross-sectional study. The knowledge was collected through a questionnaire which included 35 questions divided into three sections: demographic data, general information about epilepsy and information about epilepsy and antiepileptic drugs. The questionnaire was prepared and validated by consultant training in Ali Omer Asker Hospital in Tripoli for two months. The findings indicate that over 200 patients are altered viewed, of whom, only epileptic patients were observed. The majority of the participants were female, qualification degree BSc and years of experience from one to five years. Unfortunately, some of the participants (40.0%) had poor knowledge and about 60.0% of them had good knowledge. This study indicates that the importance of community pharmacists in Libya requires more improvement to achieve the existing function and that the impact of continuous study of everything related to diseases and medicines is important to obtain a qualified pharmacist who can become an effective agent for change.

References

1. Beghi E (2020) The epidemiology of epilepsy. Neuroepidemiology. 54 (2): 185-191. doi: 10.1159/ 000503831
2. Halvorsen KH, landmark CJ, Granas AG (2016) Prevalence of different combinations of antiepileptic drugs and CNS drugs in elderly home care service and nursing home patients in Norway. Epilepsy Research and Treatment. 2016: 1-8. doi: 10.1155/2016/5153093
3. Taher YA, Al-Gamati MA, Samud AM, El-Taher FE (2018) Knowledge and attitudes toward epilepsy among Libyan parents resident in Tripoli. Libyan Journal of Medical Sciences. 2 (3): 102-107. doi: 10.4103/LJMS. LJMS3718
4. Brodie MJ, Zuberi SM, Scheffer IE, Fisher RS (2018) The 2017 ILAE classification of seizure types and the epilepsies: what do people with epilepsy and their caregivers need to know? Epileptic Disorders. 20 (2): 77-87. doi: 10.1684/epd.2018.0957
5. Schachter SC (2020) Anticonvulsant agents: Principal considerations on effectiveness, side effects, and interactions. Neuropsychopharmacotherapy. 1-8. In: Riederer P, Laux G, Mulsant B, Le W, Nagatsu T (eds). Springer, Cham. Nature Switzerland AG. doi: 10.1007/978-3-319-56015-1_280-1
6. Reis TM, Campos M, Nagai MM, Pereira L (2016) Contributions of pharmacists in the treatment of epilepsy: a systematic review. The American Journal of Pharmacy Benefits. 8 (3): e55-e60. doi: Nil.
7. Chowdhury A, Brodie MJ (2016) Pharmacological outcomes in juvenile myoclonic epilepsy: support for sodium valproate. Epilepsy Research. 119: 62-66. doi: 10.1016/j.eplepsyres.2015.11.012
8. Sharma A, Sinha S, Narang A, Chouhan DK, Gupta S (2020) Waddling gait: A complication of valproate therapy and a thought beyond vitamin D deficiency. Sultan Qaboos University Medical Journal. 20 (1): e104. doi: 10.18295/squmj.2020.20.01.016
9. Kumar A, Maini K, Kadian R (2020) Levetiracetam. StatPearls [Internet]. Bookshelf ID: NBK499890PMID: 29763065.
10. Ozek SU, Ak HC, Ucler S (2020) Sexual dysfunction related with carbamazepine treatment: how much do we question?. Neurological Sciences. 33: 328-330. doi: 10.14744/DAJPNS.2020.00099
11. Iliescu, CATRINEL, Tarta-Arsene O, Craiu DANA (2017) Valproic acid, polycystic ovary syndrome and the adolescent with epilepsy. Farmacia. 65 (1): 1-4. doi: Nil.
12. Bansal R, Suri V, Chopra S, Aggarwal N, Sikka P, Saha SC, Goyal MK, Kumar P (2018) Levetiracetam use during pregnancy in women with epilepsy: Preliminary observations from a tertiary care center in Northern India. Indian Journal of Pharmacology. 50 (1): 39-43. doi: 10.4103/ijp.IJP_692_17
13. Uguz F, Sharma V (2016) Mood stabilizers during breastfeeding: a systematic review of the recent literature. Bipolar Disorders. 18 (4): 325-333. doi: 10.1111/bdi.12398
14. Ali MA, Mahgoub EAA, Nimir M, Ali KM (2020) Knowledge of pharmacists about anti-epileptic drugs in a developing country. Current Drug Safety. 15 (1): 32-37. doi: 10.2174/1574886314666190729114946

Citation :

Mansour et al. (2022) Assessment of knowledge and awareness of community pharmacists toward epilepsy. Mediterr J Pharm Pharm Sci. 2 (3): 17-23. [Article number: 78]. https://doi.org/10.5281/zenodo.7115139

Share :